Author Question: The school nurse is performing health assessments on students in middle school. Of which of the ... (Read 83 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
The school nurse is performing health assessments on students in middle school. Of which of the following developmental milestones should the nurse be aware?
 
  A) Height in girls increases rapidly after menarche and usually ceases immediately after menarche.
  B) Boys' growth spurt usually begins between the ages of 8 and 14 years and ends between the ages of 13 and 17 years.
  C) Peak height velocity (PHV) occurs at approximately 12 years of age in girls or about 6 to 12 months after menarche.
  D) Boys reach PHV and peak weight velocity (PWV) at about 16 years of age.

Question 2

While auscultating the heart of a 5-year-old child, the nurse notes a murmur that is soft and quiet and heard each time the heart is auscultated. The nurse documents this finding as which of the following?
 
  A) Grade 1
  B) Grade 2
  C) Grade 3
  D) Grade 4



ndhahbi

  • Sr. Member
  • ****
  • Posts: 390
Answer to Question 1

C

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Your heart beats over 36 million times a year.

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

For a complete list of videos, visit our video library